Check Cap Stock

Check Cap Stock-Based Compensation

The Stock-Based Compensation (SBC) of Check Cap (MBAI) as of Aug 11, 2026 is -12,000.00 USD. In the previous year, Stock-Based Compensation (SBC) was 12,000.00 USD — a change of -200.00% (lower).

Stock-Based Compensation

-12,000.00USD

YoY

-200.00%

Last updated:

Stock-Based Compensation (SBC) of Check Cap is 2026 -12,000.00 USD. Stock-Based Compensation (SBC) of Check Cap was 2025 12,000.00 USD. It decreases by -200.00% lower compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

Stock-Based Compensation (SBC) of Check Cap is -12,000.00 USD in 2026.

Stock-Based Compensation (SBC) of Check Cap changed from 12,000.00 USD to -12,000.00 USD, representing a -200.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Check Cap since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Check Cap historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Check Cap

All Key Metrics — Check Cap